Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

Published:2015-10-23 Issue:5 Volume:55 Page:591-597
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Grønberg Bjørn H.¹²,Halvorsen Tarje O.¹²,Fløtten Øystein³,Brustugun Odd T.⁴⁵,Brunsvig Paal F.⁴,Aasebø Ulf⁶⁷,Bremnes Roy M.⁷⁸,Tollåli Terje⁹,Hornslien Kjersti¹⁰,Aksnessæther Bjørg Y.¹¹,Liaaen Erik D.¹²,Sundstrøm Stein²,

Affiliation:

1. Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway,

2. Clinic of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway,

3. Department of Pulmonology, Haukeland University Hospital, Bergen, Norway,

4. Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway,

5. Institute of Clinical Medicine, University of Oslo, Oslo, Norway,

6. Department of Pulmonology, University Hospital of North Norway, Tromsø, Norway,

7. Department of Clinical Medicine, Faculty of Medicine, University of Tromsø, Tromsø, Norway,

8. Department of Oncology, University Hospital of North Norway, Tromsø, Norway,

9. Department of Pulmonology, Nordland Hospital, Bodø, Norway,

10. Department of Oncology, Oslo University Hospital, Ullevål Hospital, Oslo, Norway,

11. Department of Oncology, Ålesund Hospital, Ålesund, Norway, and

12. Department of Pulmonology, Ålesund Hospital, Ålesund, Norway.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1092584

Reference24 articles.

1. Sex-specific trends in lung cancer incidence and survival: a population study of 40 118 cases

2. Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

3. A Review of First-Line Treatment for Small-cell Lung Cancer

4. A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

5. Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC;JTO Clinical and Research Reports;2024-09

3. Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer?;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. The Dose/Fractionation Debate in Limited-Stage Small Cell Lung Cancer;Cancers;2024-05-17

5. Association between PET–CT accumulation in the hypothalamic/pituitary regions and neuron-specific enolase/primary tumor in limited-stage small cell lung cancer: a case-controlled retrospective study;EJNMMI Reports;2024-02-05